Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension.

Kateřina Žížalová, Barbora Nováková,Marek Vecka,Jaromír Petrtýl, Věra Lánská,Květa Pelinková,Václav Šmíd,Radan Brůha,Libor Vítek,Martin Leníček

Liver international : official journal of the International Association for the Study of the Liver（2023）

引用 2|浏览11

暂无评分

摘要

TCDCA seems to be a promising noninvasive marker of clinically significant portal hypertension. Its predictive potential may be further enhanced when it is combined with both the AST/ALT ratio and spleen diameter.

查看译文

关键词

bile acids,cirrhosis,noninvasive markers,portal hypertension,taurochenodeoxycholic acid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要